TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 2nM ΔG°: -49.7kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 2nM ΔG°: -49.7kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 2nM ΔG°: -49.7kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 3nM ΔG°: -48.6kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 3nM ΔG°: -48.6kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 4nM ΔG°: -47.9kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 5nM ΔG°: -47.4kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 5nM ΔG°: -47.4kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 5nM ΔG°: -47.4kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 6nM ΔG°: -46.9kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 6nM ΔG°: -46.9kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 6nM ΔG°: -46.9kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 6nM ΔG°: -46.9kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 6nM ΔG°: -46.9kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 7nM ΔG°: -46.5kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 8nM ΔG°: -46.2kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 8nM ΔG°: -46.2kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 8nM ΔG°: -46.2kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 8nM ΔG°: -46.2kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 8nM ΔG°: -46.2kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 8nM ΔG°: -46.2kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 8nM ΔG°: -46.2kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 8nM ΔG°: -46.2kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 9nM ΔG°: -45.9kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 9nM ΔG°: -45.9kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 9nM ΔG°: -45.9kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 9nM ΔG°: -45.9kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 9nM ΔG°: -45.9kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 10nM ΔG°: -45.7kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 10nM ΔG°: -45.7kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 10nM ΔG°: -45.7kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 10nM ΔG°: -45.7kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 10nM ΔG°: -45.7kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 11nM ΔG°: -45.4kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 12nM ΔG°: -45.2kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 12nM ΔG°: -45.2kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 13nM ΔG°: -45.0kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 14nM ΔG°: -44.8kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 15nM ΔG°: -44.7kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 15nM ΔG°: -44.7kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 15nM ΔG°: -44.7kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 15nM ΔG°: -44.7kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 16nM ΔG°: -44.5kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 16nM ΔG°: -44.5kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 16nM ΔG°: -44.5kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 17nM ΔG°: -44.3kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 17nM ΔG°: -44.3kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 17nM ΔG°: -44.3kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 17nM ΔG°: -44.3kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair
TargetProlactin-releasing peptide receptor(Homo sapiens (Human))
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
OTSUKA PHARMACEUTICAL CO., LTD.
US Patent
Affinity DataKi: 18nM ΔG°: -44.2kJ/molepH: 7.4 T: 2°CAssay Description:Receptor-expressing HEK 293 cell membrane fraction was analyzed by modifying the methods of C. J. Langmead et al. (see Langmead C J, Szekeres P G; Ch...More data for this Ligand-Target Pair